- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05330156
Transurethral Resection Versus Transurethral Enucleation of the Prostate: Prospective Randomized Study (Prostate)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Transurethral resection of the prostate (TURP) was first done in the 1920s. Since then, TURP has been considered as the gold standard treatment for BPH . However, its relatively high complication rate and postoperative recurrence necessitates further modification in the surgery technique .The resected adenomas have been reported to recur in up to 15% of cases that need a repeat surgical intervention, even by experienced surgeons in high-volume centers .
Before the era of TURP, simple open prostatectomy was the mainstay of surgical therapy. However, open simple prostatectomy has high risk of considerable intraoperative bleeding requiring transfusion. The lower abdominal incision done in open prostatectomy may result in significant postoperative pain, an extended recovery period and longer hospital stay, with greater morbidity and a perioperative mortality rate of 0.2%. In addition, TURP for large prostatic adenomas causes significantly much more bleeding with clot retention as compared to simple open prostatectomy, it also need a longer operative time, which leads to increased risk of TUR syndrome with subsequent morbidity . A new technique in which transurethral enucleation and resection of the prostate (TUERP) was developed and adopted to replicate the open enucleation of prostatic adenomas in an endoscopic way. This will combine the benefits of complete prostate enucleation in a minimally invasive technique . prostate enucleation by laser currently used as minimally invasive and save alternative to TURP, but still has not been widely accepted for some reasons, including high cost and prolonged learning curve.
TUERP technique could be used in prostates of all sizes with the same safety and efficacy "size independent procedure" . TUERP could be performed using the bipolar system only ,with or without the use of morcellator
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed F Hassan, Master
- Phone Number: 01069569946
- Email: ahmedfarahat358@gmail.com
Study Contact Backup
- Name: AHMED F HASSAN
- Phone Number: 01156522620
- Email: ahmedfarahat358@gmail.com
Study Locations
-
-
-
Assiut, Egypt, 71715
- Assiut University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- -Patients aging from 50 to 80 years old who are diagnosed with clinical symptomatic BPH.
- The patients have clear indi¬cation for endoscopic surgery (according to the guidelines).
- Clinically fit patients for surgery.
- Signed an informed consent.
Exclusion Criteria:
- Prostate cancer Previous urethral or prostate surgery Neurogenic bladder Urethral stricture Poor general condition of the patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Transurethral resection of the prostate group (TURP).
the 1st group of patients will undergone Transurethral resection of the prostate for treatment of BPH
|
- After an initial cysto-urethroscopy assessment done, Transurethral resection of the prostate is performed using the bipolar system with normal saline irrigation, under spinal or general anesthesia.
|
|
Active Comparator: transurethral enucleation of prostate group (TUEP)
the 2nd group of patients will undergone Transurethral enucleation of the prostate for treatment of BPH
|
After an initial cysto-urethroscopy assessment done, transurethral enucleation of prostate is performed using the bipolar system with normal saline irrigation, under spinal or general anesthesia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time of operation
Time Frame: intraoperative (from the start of resection or enucleation till the fixation of urethral catheter)
|
time used for resection or enucleation and resection of the prostate
|
intraoperative (from the start of resection or enucleation till the fixation of urethral catheter)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: MOHAMED F ABBAS, MD, AUH
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TURP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on BPH
-
Smita DeRecruitingBPH With Urinary Obstruction | BPH With Symptomatic Lower Urinary Tract SymptomsUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
University of North Carolina, Chapel HillBTG International Inc.Completed
-
PROCEPT BioRoboticsUnknownBPHAustralia, Lebanon, United Kingdom, Germany, New Zealand
-
Shanghai East HospitalNot yet recruiting
-
Yonsei UniversityTerminated
-
National Taiwan University HospitalCompleted
-
Boston Scientific CorporationTerminatedBPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States, Australia
Clinical Trials on Transurethral resection of the prostate
-
Sahlgrenska University HospitalVastra Gotaland RegionRecruitingBenign Prostatic HyperplasiaSweden
-
Lawson Health Research InstituteGyrus ACMI, Inc.CompletedBenign Prostatic Hyperplasia | BPHCanada
-
Assiut UniversityNot yet recruiting
-
Mansoura UniversityCompletedSexual Functions and Problems in the AdultEgypt
-
Boston Scientific CorporationCompletedBenign Prostatic HyperplasiaUnited Kingdom, Germany, Austria, Spain, Belgium, France, Italy, Netherlands, Switzerland
-
Fundacion Miguel ServetCompletedLower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Transurethral Resection of Prostate | Artery EmbolizationSpain
-
University Hospital Virgen de las NievesInstituto de Investigación Biosanitaria de Granada (ibs.Granada)RecruitingFibrosis | Hormone Deficiency | Urethral Stricture, MaleSpain
-
NeoTract, Inc.CompletedBenign Prostatic HyperplasiaDenmark, United Kingdom, Germany
-
Samsung Medical CenterCompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaKorea, Republic of